首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >Diagnosis and treatment of rheumatoid arthritis [Diagnose und Therapie der rheumatoiden Arthritis]
【24h】

Diagnosis and treatment of rheumatoid arthritis [Diagnose und Therapie der rheumatoiden Arthritis]

机译:类风湿关节炎的诊治[类风湿关节炎的诊治]

获取原文
获取原文并翻译 | 示例
       

摘要

Rheumatoid arthritis today is still not curable but satisfactory treatable. Treatment targets include clinical remission (or at least low disease activity), lack of radiological destructions and functional disability as well as acceptable life quality and unimpaired working ability. Diagnosing and adequately treating the disease as early as possible is essential for a favourable long-term outcome. Treatment to target with validation and if necessary modification at least every three months until target is achieved ensures good results. Predominantly treatment starts with a combination of methotrexate and glucocorticoids followed by a conventional DMARD combination and then addition of a biologic DMARD in case of failing target. Presence of adverse risk factors and/or high disease activity a cDMARD/bDMARD combination might be used already after starting treatment failure. Additional treatment options such as physiotherapy should be added. Altogether with current treatment possibilities burden of disease declined dramatically in recent years.
机译:今天的类风湿关节炎仍无法治愈,但可以令人满意地治愈。治疗目标包括临床缓解(或至少疾病活动程度低),缺乏放射学破坏和功能障碍以及可接受的生活质量和无损工作能力。尽早诊断和充分治疗该疾病对于长期良好的结局至关重要。经过验证的目标治疗,必要时至少每三个月进行修改,直到达到目标,才能确保取得良好的效果。主要治疗从甲氨蝶呤和糖皮质激素的组合开始,然后是常规DMARD组合,然后在靶失败的情况下添加生物DMARD。在开始治疗失败后,可能已经使用了cDMARD / bDMARD组合,存在不良危险因素和/或高疾病活动性。应该增加其他治疗选择,例如物理疗法。连同当前的治疗可能性,近年来疾病的负担急剧下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号